Department of Cardiology, Hubei Key Laboratory of Biological Targeted Therapy, Hubei Engineering Research Center for Immunological Diagnosis and Therapy of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Department of Cardiology, Binzhou Medical University Hospital, Binzhou, 256600, China.
Curr Med Sci. 2024 Aug;44(4):680-685. doi: 10.1007/s11596-024-2915-x. Epub 2024 Aug 3.
Neoatherosclerosis (NA) within stents has become an important clinical problem after coronary artery stent implantation. In-stent restenosis and in-stent thrombosis are the two major complications following coronary stent placement and seriously affect patient prognosis. As the common pathological basis of these two complications, NA plaques, unlike native atherosclerotic plaques, often grow around residual oxidized lipids and stent struts. The main components are foam cells formed by vascular smooth muscle cells (VSMCs) engulfing oxidized lipids at lipid residue sites. Current research mainly focuses on optical coherence tomography (OCT) and intravascular ultrasound (IVUS), but the specific pathogenesis of NA is still unclear. A thorough understanding of the pathogenesis and pathological features of NA provides a theoretical basis for clinical treatment. This article reviews the previous research of our research group and the current situation of domestic and foreign research.
支架内动脉新生(NA)已成为冠状动脉支架植入术后的一个重要临床问题。支架内再狭窄和支架内血栓形成是冠状动脉支架置入后的两大主要并发症,严重影响患者预后。NA 斑块作为这两种并发症的共同病理基础,不同于天然粥样硬化斑块,常围绕残留氧化脂质和支架小梁生长。主要成分是血管平滑肌细胞(VSMCs)吞噬脂质残基处氧化脂质形成的泡沫细胞。目前的研究主要集中在光学相干断层扫描(OCT)和血管内超声(IVUS),但 NA 的具体发病机制仍不清楚。深入了解 NA 的发病机制和病理特征为临床治疗提供了理论基础。本文就本课题组既往研究及国内外研究现状进行综述。